Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1114

Bifidobacterium breve DSM 33444

Intended Use: Intended for use as an ingredient in non-exempt infant formula for term infants at a level up to 1.0 x 108 colony forming units (CFU)/g, as well as in conventional foods at levels up to 5.0 x 109 CFU/g.
Basis: Scientific procedures
Notifier: Chr. Hansen A/S
Notifier Address: Boege Allé 10-12
2970 Hoersholm
Denmark
GRAS Notice (releasable information): GRN 1114 with amendments (in PDF) (4.7 MB)
Date of closure: Jul 10, 2023
FDA's Letter: FDA has no questions (in PDF) (141 kB)
-
-